Home
 /
Papers
 /
Synthetic Biology
 /
A Scalable Design for Proximity-Inducing Molecules
Preprint
Open access
V1
Top 1% · Validated by QED

A Scalable Design for Proximity-Inducing Molecules

Endri Karaj, Varsha Venkatarangan, Shaimaa H. Sindi +20 more
February 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.02.20.706349
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Synthetic Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By repurposing enzyme inhibitors as group-transfer handles rather than discarding them as incompatible, GRIPs overturn the core scalability bottleneck of proximity-inducing chimeras and unlock endogenous PTM editing across diverse targets and modifications.

QED claims analysis

Summary

GRIPs (GRoup-transfer chimeras for Inducing Proximity) provide a scalable platform for post-translational modification editing by converting abundant, high-quality inhibitors of writer and eraser enzymes into proximity-inducing molecules through tunable group-transfer handles that covalently append protein-of-interest binders onto endogenous enzymes. This inhibitor-based approach enables bidirectional control of O-GlcNAcylation, tyrosine phosphorylation, and serine/threonine phosphorylation across 16 enzyme-POI pairs, achieving superior specificity compared to activator-based chimeras while enabling novel therapeutic applications including prevention of JAK inhibitor rebound signaling, enhanced STAT3 inhibition potency, and selective cancer cell killing through therapeutic overactivation of oncogenic EGFR signaling.

See full analysis
Main Claim 1 –

GRIPs Recruit Endogenous SHP2 to Dephosphorylate Tagged Proteins

Supporting evidence

  • PDB Mining Identifies Inhibitors Near Cysteines in Writers/Erasers
  • SHP2 GRIPs Show Highly Specific Cellular Target Engagement
  • SHP2 GRIPs Dephosphorylate Ser/Thr Sites as Well as Tyr
Main Claim 2 –

SHP2–JAK2 GRIPs Prevent JAK Inhibitor Withdrawal Rebound Signaling

Supporting evidence

  • SHP2–STAT3 GRIPs Outperform Occupancy-Based STAT3 Inhibitors in Potency
  • SHP2–EGFR GRIPs Yield More Persistent Inhibition than GePhos1
Main Claim 3 –

GRIPs Recruit Endogenous OGA for Specific O-GlcNAc Removal

Supporting evidence

  • OGA GRIPs Achieve >128-Fold Selective OGA Enrichment Proteomics
  • Methacrylamide Handles Fail with Weakly Basic Covalent Inhibitors
  • Tunable Handles Enable GRIPs from Poor-Leaving-Group Covalent Inhibitors
Main Claim 4 –

GRIPs Recruit Endogenous OGT to Add O-GlcNAc to POIs

Supporting evidence

  • Lysine-Targeting Handles Expand GRIPs Beyond Cysteine-Accessible Proteins
  • Lysine-Based GRIPs Enable Protein Recruitment and BRD4 Phosphorylation

Abstract

Chimeric molecules, which bring together an effector enzyme and a protein-of-interest (POI) to add/remove post-translational modifications (PTMs), are furnishing transformative modalities (e.g., PROTACs). However, these chimeras’ scalability is limited as they employ rare, non-inhibitory binders of effectors. We report GRoup-transfer chimeras for Inducing Proximity (GRIPs) that employ abundantly available effectors’ inhibitors to append POI binder on the effector using group-transfer handles. To demonstrate scalability, we develop 6 GRIPs classes for 3 PTMs utilizing diverse inhibitor, spanning 16 effector‒POI pairs. Furthermore, we report a toolbox of 42 tunable group-transfer handles for Cys/Lys residues and ∼5000 inhibitor‒residue pairs for diverse effectors. Using global proteomics, we confirm the specificity for group transfer and PTM editing. GRIPs endowed new functionalities to POI drugs, including preventing rebound signaling upon drug withdrawal, a more potent/persistent inhibition, and inhibitor-induced pathway activation in 4 fully-endogenous systems. In diverse hemi-endogenous systems (tagged POI), GRIPs induced condensate formation with reduced off-targets, cleared pathogenic PTMs, and initiated PTM crosstalk. Overall, GRIPs provide a scalable and versatile platform for PTM editing.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?